Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes
- 1 May 1996
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 2 (5) , 551-555
- https://doi.org/10.1038/nm0596-551
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the DonorNew England Journal of Medicine, 1995
- Production of Genetically Modified Epstein-Barr Virus-Specific Cytotoxic T Cells for Adoptive Transfer to Patients at High Risk of EBV-Associated Lymphoproliferative DiseaseJournal of Hematotherapy, 1995
- Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferationThe Lancet, 1995
- Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative diseaseBritish Journal of Haematology, 1995
- Principles for Adoptive T Cell Therapy of Human Viral DiseasesAnnual Review of Immunology, 1995
- Donor T Cells to Treat EBV-Associated LymphomaNew England Journal of Medicine, 1994
- CD8+ T-cell memory to virusesCurrent Opinion in Immunology, 1994
- Memories are made of this?Nature, 1994
- Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1994
- Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.The Journal of Experimental Medicine, 1992